This medication has a relatively long duration of action in the body, taking an average of 113 hours to be half metabolized. This means that the drug ···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 73
After oral administration, the drug concentration in the blood reaches its peak in approximately 4 to 6 hours; this time point is known as the "t···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 74
During medication, it is necessary to perform routine blood tests, blood biochemistry tests, and electrocardiograms regularly as prescribed by the doc···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 75
What are the adverse reactions of gefitinib fumarate tablets?Common reactions include: abnormal liver function (elevated ALT/AST), anemia, thrombocyto···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 74
Which drugs may interact with gefitinib fumarate tablets?Before taking any medication, you should inform your doctor in detail about all medications y···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 74
What medications are commonly used in conjunction with gefitinib fumarate tablets?During treatment, doctors may combine gefitinib fumarate tablets wit···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 73
Function and efficacyThe main ingredient of Gilteritinib fumarate tablets is Gilteritinib fumarate, which is an anti-tumor drug.Please take this medic···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 75
FDA Approval AnnouncementOn November 19, 2025, AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Koselugo (selumetin···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 71
FDA Approval AnnouncementOn September 10, the U.S. Food and Drug Administration (FDA) approved Koselugo (selumetinib) oral granules and capsules, an o···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 72
EMA CHMP Positive Review OpinionRecently, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a po···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 70
NDA Submission AnnouncementOn May 26, 2020, Bayer announced the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, Labour ···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 70
FDA Approval AnnouncementNovember 26, 2018 -- The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib).Vit···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 70
Approval AnnouncementWHIPPANY, N.J.--(BUSINESS WIRE) April 10, 2025 --Bayer today announced that the U.S. Food and Drug Administration (FDA) has grant···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 71
Sometimes it is not safe to use certain medications at the same time.Some drugs can affect your blood levels of other drugs you take, which may increa···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 71
Avoid driving or hazardous activity until you know how larotrectinib will affect you. Your reactions could be impaired.Grapefruit may interact with la···【Read More】
Update: 2026-03-11Source: Haiou HealthViews: 70
Copyright2024@ BIGBEAR All right reserved BIGBEAR



